|
Neonatal Intensive Care Drug Manual
|
| bet | 365/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Contraindications
|
Severe obstructive aortic or pulmonary valvular disease or hypertrophic subaortic stenosis. Hypersensitivity to milrinone, other 3,4'-bipyridines (inamrinone) or any other ingredient of the formulation.
|
Precautions
|
Ensure adequate circulating blood volume prior to commencement.
Loading dose: Considered optional depending on clinical circumstances. May cause hypotension. Monitor BP and heart rate closely and ensure adequate volume replacement.
Prematurity: Long half-life reported (10 hours) in very preterm infants.5 Avoid prolonged higher rate infusion ≥0.2 microgram/kg/minute.
|
|
| |
